期刊文献+

学生接种甲型H1N1流感疫苗免疫原性与持久性观察 被引量:5

Observation on immunogenicity of pandemic influenza A (H1N1) vaccine and its persistence among students
原文传递
导出
摘要 目的通过对学生接种甲型H1N1流感疫苗的免疫原性及持久性观察,为今后甲型H1N1流感疫苗的使用与免疫策略提供参考依据。方法选择辖区内某中学初三年级学生为研究对象,以知情自愿为原则,于上臂三角肌处接种一剂国产甲型H1N1流感疫苗,并于接种前、接种后1、3、6个月和1年采集血清,检测不同时间段甲型H1N1流感HI抗体情况。结果学生免前甲型H1N1流感HI抗体阳性率为35.68%,免后1个月HI抗体阳转率为75.14%,阳性率为92.43%,GMT(倒数)为177.42,增长9.32倍,免后1年HI抗体阳性率仍在84.21%、GMT(倒数)93.03水平。结论国产甲型H1N1流感疫苗具有较好的免疫原性与免疫持久性,免疫后1年不用再次免疫。 Objective To understand the immunogenicity of pandemic influenza A(H1N1) vaccine and its persistence among students and provide scientific evidence for the future use of pandemic influenza A(H1N1) vaccine and development of immunization strategies.Methods The middle school students in Xiuzhou were selected on basis of informed consent,the students were given a injection of H1N1 vaccine manufactured in China.The blood samples were taken from them before vaccination and at 1,3,6 months and I year after vaccination to detect HI antibodies to pandemic influenza A(H1N1) virus at different phases.Results The positive rate of HI antibody was 35.68% among the students before vaccination.The positive conversion rate of HI antibody was 75.14% and the positive rate was 92.43% one month after vaccination.The GMT(reciprocal) was 177.42,an increase of 9.32 times.The antibody conversion rate remained to be 84.21% and the GMT(reciprocal) was 93.03 one year after vaccination,Conclusion The domestic H1N1 vaccine has good immunogenicity which can last for long time.There is no need to re-vaccinate one year later.
出处 《疾病监测》 CAS 2011年第9期685-688,共4页 Disease Surveillance
关键词 甲型H1N1流感疫苗 免疫原性 持久性 pandemic influenza A(H1N1) vaccine immunogenicity persistence
  • 相关文献

参考文献8

  • 1Centers for Disease Control and Prevention (CDC). Swine influenzaA/H1N1 infection in two children-Southern California, March-April 2009 E J ]. MMWR Morb Mortal Wkly Rep,2009 ,58 (15) :400 -402.
  • 2Centers for Disease Control and Prevention (CDC). Safety of influenzaA ( H1N1 ) 2009 monovalent vaccines-United States, October 1 -November 24,2009[J]. MMWR Morb Mortal Wkly Rep ,2009,58:1351 - 1356.
  • 3卫生部.2009年秋冬季甲型HlNl流感疫苗预防接种指导意见[S].北京:卫生部,2009.
  • 4张雪峰,方捍华,赵静,余录根,张艺飓,朱凤才.流行性感冒病毒裂解疫苗临床安全性及免疫原性研究[J].中国计划免疫,2005,11(5):348-351. 被引量:18
  • 5段玮,杨鹏,田丽丽,张奕,王小莉,庞星火,邓瑛,王全意,刘民.2009年北京市学生甲型H1N1流感流行特征[J].首都公共卫生,2010,4(3):99-102. 被引量:4
  • 6European Agency for the Evaluation of Medicinal Products for Human Use. European Committee for Medicinal Products for Human Use. Guideline on dossier structure and content for pandemic influenza vaccine marketing authorisation application ( EMEACPMP/VEG/4717 /03 ) [ EB/OL J 2008. http ://www. emea. europa, eu/pdfs/human/vwp/471703en.
  • 7Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research. Guidance for industry : clinical data needed to support the licensure of pandemic influenza vaccines [EB/OL]. May 2007. http:// www. fda. gov/ BiologicsBloodVaccines/GuidanceCompliance Regulatorylnformation/Guidances/Vaccines/ucm074786. htm.
  • 8姜柯羽,王华庆,梁晓峰.免疫前抗体水平对甲型H_1N_1流行性感冒疫苗免疫原性的影响[J].中国疫苗和免疫,2010,16(5):393-399. 被引量:3

二级参考文献26

  • 1徐天强,李燕婷,吴寰宇,张爱香,袁国娟,孔利群,顾宝柯.流感疫苗安全性和免疫效果观察[J].上海预防医学,2000,12(9):432-434. 被引量:16
  • 2中华人民共和国卫生部.四川省确诊一例甲型H1N1流感病例.http://www.gov.cn/gzdt/2009-05/11/content_1310592.html,2010-4-16.
  • 3中华人民共和国卫生部.《甲型H1N1流感诊疗方案(2009年第三版)》http://61.49.18.65/publiefiles/business/htmlfiles/mohyzs/s3586/200910/43111.htm.2010-4-16.
  • 4Justin Lessler,Nicholas G,Reich.Outbreak of 2009 Pandemic Influenza A (H1N1) at a New York City School.NFJM,2009,(3):2628-2636.
  • 5卫生部.2009年秋冬季甲型H1N1流感疫苗预防接种指导意见[s].2009-09-10.
  • 6XiaoFeng Liang,HuaQing Wang,JunZhi Wang,et al.Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China:a muhicentre,double-blind,randomised,placebo-controlled trial [ J ].Lancet,2010,375(9708):56-66.
  • 7Van Essen GA,Palache AM,Forleo E,et al.Influenza vaccination in 2000:recommendations and vaccine use in 50 developed and rapidly developing eountries[J].Vaccine, 2003, 21(16): 1780-1785.
  • 8Nolan T,McVernon J,Skeljo M,et al.Immunogenicity of a monovalent 2009 influenza A(H1N1) vaecine in infants and children :a randomized trial [ J ]. JAMA, 2010, 303(1 ): 37-46.
  • 9Plennevaux E,Sheldon E, Blatter M, et al. Immune response after a single vaccination against 2009 influenza A H1N1 in USA:a preliminary report of two randomized controlled phase 2 trials[J]. Lancet, 2010, 375(9708): 41-48.
  • 10Clark Tw, Pareek M, Hoschler K, et al. Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvantexl vaccine[J]. N Engl J Med, 2009, 361 (25): 2424-2435.

共引文献22

同被引文献44

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部